Paper39458609
Application of Gold Nanoparticles for Improvement of Electroporation-Assisted Drug Delivery and Bleomycin Electrochemotherapy.
Lekešytė B and 11 others. Pharmaceutics, 2024. Cited by 7 papers, by iCite.
Cite this record
ConductScience Library. Application of Gold Nanoparticles for Improvement of Electroporation-Assisted Drug Delivery and Bleomycin Electrochemotherapy. Papers, record 39458609. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39458609
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Application of Gold Nanoparticles for Improvement of Electroporation-Assisted Drug Delivery and Bleomycin Electrochemotherapy.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| S-MIP-24-580 | Research Council of Lithuania | PubMed |
Source PubMed
References30
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 31869699 | Contactless electroporation induced by high intensity pulsed electromagnetic fields via distributed nanoelectrodes. | Bioelectrochemistry | 2020 | https://conductscience.org/library/papers/31869699 | PubMed |
| 2 | 28391185 | Bipolar Microsecond Pulses and Insulated Needle Electrodes for Reducing Muscle Contractions During Irreversible Electroporation. | IEEE Trans Biomed Eng | 2017 | https://conductscience.org/library/papers/28391185 | PubMed |
| 3 | 36077875 | Electrochemotherapy: An Alternative Strategy for Improving Therapy in Drug-Resistant SOLID Tumors. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/36077875 | PubMed |
| 4 | 36551739 | High-Frequency Nanosecond Bleomycin Electrochemotherapy and its Effects on Changes in the Immune System and Survival. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/36551739 | PubMed |
| 5 | 16545779 | Nanosecond pulsed electric fields cause melanomas to self-destruct. | Biochem Biophys Res Commun | 2006 | https://conductscience.org/library/papers/16545779 | PubMed |
| 6 | 32980738 | Electrophoresis-assisted accumulation of conductive nanoparticles for the enhancement of cell electropermeabilization. | Bioelectrochemistry | 2021 | https://conductscience.org/library/papers/32980738 | PubMed |
| 7 | 15267418 | Plasmon hybridization in spherical nanoparticles. | J Chem Phys | 2004 | https://conductscience.org/library/papers/15267418 | PubMed |
| 8 | 30021498 | ESOPE-Equivalent Pulsing Protocols for Calcium Electroporation: An In Vitro Optimization Study on 2 Cancer Cell Models. | Technol Cancer Res Treat | 2018 | https://conductscience.org/library/papers/30021498 | PubMed |
| 9 | 26271592 | Magnetic nanoparticle-based drug delivery for cancer therapy. | Biochem Biophys Res Commun | 2015 | https://conductscience.org/library/papers/26271592 | PubMed |
| 10 | 18978447 | Use of conductive gels for electric field homogenization increases the antitumor efficacy of electroporation therapies. | Phys Med Biol | 2008 | https://conductscience.org/library/papers/18978447 | PubMed |
| 11 | 37630998 | Calcium Electrochemotherapy for Tumor Eradication and the Potential of High-Frequency Nanosecond Protocols. | Pharmaceuticals (Basel) | 2023 | https://conductscience.org/library/papers/37630998 | PubMed |
| 12 | 21900067 | Equivalent pulse parameters for electroporation. | IEEE Trans Biomed Eng | 2011 | https://conductscience.org/library/papers/21900067 | PubMed |
| 13 | 37111663 | Improving NonViral Gene Delivery Using MHz Bursts of Nanosecond Pulses and Gold Nanoparticles for Electric Field Amplification. | Pharmaceutics | 2023 | https://conductscience.org/library/papers/37111663 | PubMed |
| 14 | 25229176 | Electroporation in cancer therapy without insertion of electrodes. | Phys Med Biol | 2014 | https://conductscience.org/library/papers/25229176 | PubMed |
| 15 | 33743336 | Electroporation with nanosecond pulses and bleomycin or cisplatin results in efficient cell kill and low metal release from electrodes. | Bioelectrochemistry | 2021 | https://conductscience.org/library/papers/33743336 | PubMed |
| 16 | 24749393 | Gold nanoparticles enhanced electroporation for mammalian cell transfection. | J Biomed Nanotechnol | 2014 | https://conductscience.org/library/papers/24749393 | PubMed |
| 17 | 26355870 | Mitigation of impedance changes due to electroporation therapy using bursts of high-frequency bipolar pulses. | Biomed Eng Online | 2015 | https://conductscience.org/library/papers/26355870 | PubMed |
| 18 | 17668934 | Mathematical modeling of irreversible electroporation for treatment planning. | Technol Cancer Res Treat | 2007 | https://conductscience.org/library/papers/17668934 | PubMed |
| 19 | 28260889 | Gold nanoparticles and electroporation impose both separate and synergistic radiosensitizing effects in HT-29 tumor cells: an in vitro study. | Int J Nanomedicine | 2017 | https://conductscience.org/library/papers/28260889 | PubMed |
| 20 | 38612865 | Gold Nanoparticles (AuNPs)-Toxicity, Safety and Green Synthesis: A Critical Review. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38612865 | PubMed |
Cited by5
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42883690 | Advancing Electrochemotherapy in Melanoma and Non-Melanoma Skin Cancer: From Clinical Practice to Emerging Frontiers. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42883690 | PubMed |
| 41463389 | Gold Nanoparticles-Enhanced Gene Transfer Driven by MHz-Frequency Nanosecond Pulsed Electric Fields. | Biomolecules | 2025 | https://conductscience.org/library/papers/41463389 | PubMed |
| 41373426 | Nanosecond Pulsed Electric Fields (nsPEFs) for Precision Intracellular Oncotherapy: Recent Advances and Emerging Directions. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41373426 | PubMed |
| 40870986 | Limited Efficacy of Nanoparticle-Assisted Electroporation for Membrane Permeabilization and Gene Electrotransfer. | Pharmaceutics | 2025 | https://conductscience.org/library/papers/40870986 | PubMed |
| 39591094 | Gold Nanoparticles in Nanomedicine: Unique Properties and Therapeutic Potential. | Nanomaterials (Basel) | 2024 | https://conductscience.org/library/papers/39591094 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39458609
GET https://conductscience.org/api/papers/v1/39458609/references?page=2